As of 2025-10-16, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (92.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.48 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -2155.2%.
The range of the Relative Valuation is (87.26) - (97.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.9x | 15.0x |
| Forward P/E multiples | 14.2x - 15.8x | 15.0x |
| Fair Price | (87.26) - (97.07) | (92.07) |
| Upside | -2047.9% - -2266.7% | -2155.2% |
| Date | P/E |
| 2025-10-10 | -0.78 |
| 2025-10-09 | -0.87 |
| 2025-10-08 | -0.80 |
| 2025-10-07 | -0.81 |
| 2025-10-06 | -0.86 |
| 2025-10-03 | -0.88 |
| 2025-10-02 | -0.86 |
| 2025-10-01 | -0.82 |
| 2025-09-30 | -0.74 |
| 2025-09-29 | -0.75 |
| 2025-09-26 | -0.74 |
| 2025-09-25 | -0.70 |
| 2025-09-24 | -0.71 |
| 2025-09-23 | -0.66 |
| 2025-09-22 | -0.56 |
| 2025-09-19 | -0.61 |
| 2025-09-18 | -0.48 |
| 2025-09-17 | -0.47 |
| 2025-09-16 | -0.49 |
| 2025-09-15 | -0.50 |
| 2025-09-12 | -0.49 |
| 2025-09-11 | -0.51 |
| 2025-09-10 | -0.54 |
| 2025-09-09 | -0.57 |
| 2025-09-08 | -0.58 |
| 2025-09-05 | -0.57 |
| 2025-09-04 | -0.52 |
| 2025-09-03 | -0.53 |
| 2025-09-02 | -0.50 |
| 2025-08-29 | -0.50 |
| 2025-08-28 | -0.49 |
| 2025-08-27 | -0.50 |
| 2025-08-26 | -0.52 |
| 2025-08-25 | -0.49 |
| 2025-08-22 | -0.48 |
| 2025-08-21 | -0.48 |
| 2025-08-20 | -0.45 |
| 2025-08-19 | -0.46 |
| 2025-08-18 | -0.48 |
| 2025-08-15 | -0.47 |
| 2025-08-14 | -0.45 |
| 2025-08-13 | -0.43 |
| 2025-08-12 | -0.40 |
| 2025-08-11 | -0.37 |
| 2025-08-08 | -0.37 |
| 2025-08-07 | -0.40 |
| 2025-08-06 | -0.41 |
| 2025-08-05 | -0.41 |
| 2025-08-04 | -0.41 |
| 2025-08-01 | -0.38 |